# Maximus share price today (Maximus, Inc., MMS)

> Maximus, Inc.'s P/E is near the low end of its own history, higher than only 12% of past readings, and its quarterly results are still getting worse. MMS · Industrials · Specialty Business Services · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/mms

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $65.46 (−21.2% in a year)
- P/E: 9.7× (lower than 88% of the last 4.6 years)
- Revenue (Jun 2026): $1.3 B (−5.1% on a year ago)
- Profit (Jun 2026): $104 M (−2.3% on a year ago)
- Operating margin: 12.6% (+0.3 points on a year ago)
- ROE: 19%, FY25
- ROIC: 13.3%, against a 6.1% cost of capital: +7.2 points

The main question: yearly earnings per share moved +10.4% while the share price moved −21.2%. ## What is the Maximus share price today? Maximus, Inc.'s share price was $65.46 at the close on 3 November 2026. It has been stalling near its high for 1 week. That is 1.5% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 5 weeks in a row. In the last 52 weeks it traded between $53 and $99, and at that close it sat 28% of the way up from that low. Over the last 10 years the share price moved +13% while the S&P 500 moved +255%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Maximus pay? Maximus, Inc. paid $1.29 per share over the last four reported quarters. The most recent declaration was $0.33 for Jun 2026. At today's price of $65.46 that is a yield of 1.97%, based on dividends already paid, not a forecast. ## Which stock lists is Maximus on? Maximus is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Maximus profitable? Maximus, Inc. earned $104 M of net profit in the Jun 2026 quarter, −2.3% on the same quarter a year earlier. Full-year FY25 profit was $319 M. Over 4 years profit has grown 2.3% a year on average. That is 8.1% of the quarter's revenue. The same quarter a year earlier earned $106 M. For the full year, FY25 profit was $319 M (+3.9% on the year before). Why profit moved: revenue changed −5.1% on a year earlier and the margin moved +0.3 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +32.8% and revenue −3.3%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Maximus make, and is it growing? Maximus, Inc. reported $1.3 B of revenue in the Jun 2026 quarter, −5.1% on the same quarter a year earlier. Over 4 years it has grown 6.3% a year on average. The last full year, FY25, came in at $5.4 B. The last four reported quarters add to $5.2 B. FY25 revenue was $5.4 B, +2.4% on the year before. Recent pace: the last four quarters grew −3.3% on average, against 6.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −3.3%, against +0.0% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +17.3%, against +12.4% a year (accelerating). ## How much of every $100 of sales does Maximus keep? Maximus, Inc.'s operating margin was 12.6% in the Jun 2026 quarter, 0.3 percentage points higher than the same quarter a year ago. Across 5 years it has been between 6.0% and 9.8%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +0.3 percentage points on the year while gross margin changed +0.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Maximus' profit turning into cash? Over the last 3 years, 160% of Maximus, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $429 M of operating cash against $319 M of profit. After $63.2 M of spending on assets, $366 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Maximus' cash go? Maximus, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $286 M on assets over the last 3 years. Averaged over those years that is 1.8% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $286 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Maximus' P/E ratio, and how does it compare with its own history? Maximus, Inc.'s P/E is 9.7×, near the low end of its own history: it has been lower only 12% of the time. Its usual P/E (the middle reading) is 18.0×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +10.4% while the price moved −21.2%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved −5.3% a year; about +37.0% a year came from earnings growth and about −42.3 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Maximus business getting better or worse? Maximus, Inc.'s business is giving mixed signals. Growth has been steadily positive, but ROCE at 14.5% is below the 15% level needed to call it steady growth. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Maximus earn on its capital? Maximus, Inc. earned a ROE of 19% in FY25. That is up from a low of 10% in FY23. Its return on capital used (ROIC) is 7.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 5.9% net margin and 1.33× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 5.9% net margin × 1.33× asset turnover × 2.43× leverage (assets divided by equity) ≈ 19.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 13.3% − 6.1% = +7.2 percentage points. The 6.1% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Maximus have too much debt? Maximus, Inc. has total debt of $1.7 B against shareholder equity of $1.7 B as of Jun 2026, so its debt is 1.00× its equity. Year by year, that ratio went from 1.15 in FY21 to 0.86 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Maximus shareholding pattern? 6.8% of Maximus, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Maximus from balance-sheet trouble? For Maximus, Inc., the Z-score is 3.24. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.24 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Maximus rank in its industry? 57.5 out of 100, rank 6 of 30 in Specialty Business Services, with 81% of the evidence available. Maximus, Inc. scores 57.5 out of 100 against the 30 companies it is compared with in Specialty Business Services, ranking 6. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 17.1 + 15.8 + 16.2 + 8.4 = 57.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Maximus compared with? Maximus ranks 6 of 30 Specialty Business Services companies on the 4-Factor Sector Score, with 57.5 out of 100. 1. [Cintas Corporation](https://www.sectoralpha.in/us/stocks/ctas) CTAS · leader · Most evidence points up · 85% evidence 68.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.9/35 · Revenue 9.5% · Profit 11.3% · Operating margin change 1.4 points · 95% evidence Capital efficiency 21.0/25 · ROCE 34.3% · Operating margin 24.1% · 76% evidence Valuation 6.1/20 · P/E 39.3× · PEG 3.17 · 65% evidence Relative strength 17.3/20 · Lead over its industry 3.9% · Lead over S&P 500 11.8% · 1 year 20.9% · 100% evidence · 10 of 12 weeks ahead Exact sum: 23.9 + 21 + 6.1 + 17.3 = 68.3 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [UL Solutions Inc.](https://www.sectoralpha.in/us/stocks/uls) ULS · turning · Most evidence points up · 81% evidence 66.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.0/35 · Revenue 6.6% · Profit 54.4% · Operating margin change 0.7 points · 83% evidence Capital efficiency 20.5/25 · ROCE 26.4% · Operating margin 18.4% · 76% evidence Valuation 13.0/20 · P/E 40.7× · PEG 0.77 · 65% evidence Relative strength 8.1/20 · Lead over its industry -13.8% · Lead over S&P 500 -7.3% · 1 year -6.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 25 + 20.5 + 13 + 8.1 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [RELX PLC](https://www.sectoralpha.in/us/stocks/relx) RELX · breaking out · Too little evidence to rank firmly · 51% evidence 65.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.8/35 · Revenue n/a · Profit n/a · Operating margin change 1.1 points · 26% evidence Capital efficiency 21.6/25 · ROCE 36.1% · Operating margin 32% · 76% evidence Valuation 10.4/20 · P/E 18.3× · PEG n/a · 15% evidence Relative strength 13.9/20 · Lead over its industry -2.9% · Lead over S&P 500 4.6% · 1 year -6.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 19.8 + 21.6 + 10.4 + 13.9 = 65.7 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 4. [ABM Industries Incorporated](https://www.sectoralpha.in/us/stocks/abm) ABM · leader · Evidence leans up · 85% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Revenue 6% · Profit 44% · Operating margin change 0.5 points · 95% evidence Capital efficiency 10.2/25 · ROCE 8.3% · Operating margin 4.3% · 76% evidence Valuation 15.5/20 · P/E 16.9× · PEG 0.33 · 65% evidence Relative strength 17.8/20 · Lead over its industry 6.1% · Lead over S&P 500 14.1% · 1 year 27.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 19.5 + 10.2 + 15.5 + 17.8 = 63 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Cass Information Systems, Inc.](https://www.sectoralpha.in/us/stocks/cass) CASS · quiet · Evidence leans up · 85% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.5/35 · Revenue 6.4% · Profit 21.9% · Operating margin change 0.5 points · 95% evidence Capital efficiency 13.1/25 · ROCE 7.1% · Operating margin 29.7% · 76% evidence Valuation 14.8/20 · P/E 17.9× · PEG 0.72 · 65% evidence Relative strength 10.5/20 · Lead over its industry -1.4% · Lead over S&P 500 5.8% · 1 year 36% · 100% evidence · 5 of 12 weeks ahead Exact sum: 22.5 + 13.1 + 14.8 + 10.5 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. Maximus, Inc. this page MMS · breaking out · Evidence leans up · 81% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue -3.3% · Profit 17% · Operating margin change 0.3 points · 83% evidence Capital efficiency 15.8/25 · ROCE 14.6% · Operating margin 12.6% · 76% evidence Valuation 16.2/20 · P/E 7.6× · PEG 0.31 · 65% evidence Relative strength 8.4/20 · Lead over its industry -16.7% · Lead over S&P 500 -10% · 1 year -22.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 17.1 + 15.8 + 16.2 + 8.4 = 57.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [CBIZ, Inc.](https://www.sectoralpha.in/us/stocks/cbz) CBZ · Evidence leans up · 65% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/43.75 · Revenue 3.8% · Profit 34.6% · Operating margin change 2 points · 95% evidence Capital efficiency 13.5/31.25 · ROCE 7.7% · Operating margin 13.3% · 76% evidence Valuation 18.4/25 · P/E 20.7× · PEG 0.4 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 25.6 + 13.5 + 18.4 = 57.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 8. [Thomson Reuters Corporation](https://www.sectoralpha.in/us/stocks/tri) TRI · breaking out · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 7% · Profit 1.6% · Operating margin change 4.2 points · 83% evidence Capital efficiency 17.0/25 · ROCE 15.7% · Operating margin 28.3% · 76% evidence Valuation 5.5/20 · P/E 21.5× · PEG 6.29 · 65% evidence Relative strength 12.2/20 · Lead over its industry -6.9% · Lead over S&P 500 0.5% · 1 year -21.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21.4 + 17 + 5.5 + 12.2 = 56.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 9. [First Advantage Corporation](https://www.sectoralpha.in/us/stocks/fa) FA · quiet · Evidence leans up · 74% evidence 53.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Revenue 32.8% · Profit n/a · Operating margin change 2.6 points · 62% evidence Capital efficiency 9.2/25 · ROCE 4.9% · Operating margin 12.8% · 76% evidence Valuation 4.3/20 · P/E 123.1× · PEG 4.11 · 65% evidence Relative strength 14.7/20 · Lead over its industry 21.2% · Lead over S&P 500 29.7% · 1 year 63.9% · 100% evidence · 7 of 12 weeks ahead Exact sum: 25.6 + 9.2 + 4.3 + 14.7 = 53.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [LegalZoom.com, Inc.](https://www.sectoralpha.in/us/stocks/lz) LZ · turning · Evidence leans up · 74% evidence 53.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 12% · Profit -41.4% · Operating margin change 7 points · 62% evidence Capital efficiency 15.9/25 · ROCE 23.1% · Operating margin 5.4% · 76% evidence Valuation 3.9/20 · P/E 62.4× · PEG 9.26 · 65% evidence Relative strength 8.5/20 · Lead over its industry -17.4% · Lead over S&P 500 -10.7% · 1 year -33.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 24.8 + 15.9 + 3.9 + 8.5 = 53.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Global Payments Inc.](https://www.sectoralpha.in/us/stocks/gpn) GPN · turning · Evidence leans up · 71% evidence 52.7 out of 100 Growth Capital Valuation Relative
12. [Aramark](https://www.sectoralpha.in/us/stocks/armk) ARMK · turning · Evidence leans up · 64% evidence 52.0 out of 100 Growth Capital Valuation Relative
13. [TIC Solutions, Inc.](https://www.sectoralpha.in/us/stocks/tic) TIC · breaking out · Evidence leans down · 61% evidence 49.0 out of 100 Growth Capital Valuation Relative
14. [Eastman Kodak Company](https://www.sectoralpha.in/us/stocks/kodk) KODK · quiet · Evidence leans down · 64% evidence 47.8 out of 100 Growth Capital Valuation Relative
15. [Dolby Laboratories, Inc.](https://www.sectoralpha.in/us/stocks/dlb) DLB · losing its lead · Evidence leans down · 81% evidence 47.0 out of 100 Growth Capital Valuation Relative
16. [Rentokil Initial plc](https://www.sectoralpha.in/us/stocks/rto) RTO · basing · Too little evidence to rank firmly · 51% evidence 46.7 out of 100 Growth Capital Valuation Relative
17. [Transcat, Inc.](https://www.sectoralpha.in/us/stocks/trns) TRNS · quiet · Evidence leans down · 81% evidence 45.3 out of 100 Growth Capital Valuation Relative
18. [AZZ Inc.](https://www.sectoralpha.in/us/stocks/azz) AZZ · quiet · Evidence leans down · 85% evidence 45.0 out of 100 Growth Capital Valuation Relative
19. [Copart, Inc.](https://www.sectoralpha.in/us/stocks/cprt) CPRT · turning · Evidence leans down · 85% evidence 43.3 out of 100 Growth Capital Valuation Relative
20. [RB Global, Inc.](https://www.sectoralpha.in/us/stocks/rba) RBA · turning · Evidence leans down · 81% evidence 42.8 out of 100 Growth Capital Valuation Relative
21. [Target Hospitality Corp.](https://www.sectoralpha.in/us/stocks/th) TH · quiet · Evidence leans down · 64% evidence 42.2 out of 100 Growth Capital Valuation Relative
22. [Amentum Holdings, Inc.](https://www.sectoralpha.in/us/stocks/amtm) AMTM · basing · Evidence leans down · 64% evidence 40.7 out of 100 Growth Capital Valuation Relative
23. [Quad/Graphics, Inc.](https://www.sectoralpha.in/us/stocks/quad) QUAD · losing its lead · Evidence leans down · 64% evidence 40.4 out of 100 Growth Capital Valuation Relative
24. [Cimpress plc](https://www.sectoralpha.in/us/stocks/cmpr) CMPR · quiet · Evidence leans down · 64% evidence 36.7 out of 100 Growth Capital Valuation Relative
25. [BlackSky Technology Inc.](https://www.sectoralpha.in/us/stocks/bksy) BKSY · quiet · Evidence leans down · 64% evidence 36.6 out of 100 Growth Capital Valuation Relative
26. [UniFirst Corporation](https://www.sectoralpha.in/us/stocks/unf) UNF · quiet · Evidence leans down · 85% evidence 36.4 out of 100 Growth Capital Valuation Relative
27. [Resolute Holdings Management, Inc.](https://www.sectoralpha.in/us/stocks/rhld) RHLD · basing · Most evidence points down · 64% evidence 31.9 out of 100 Growth Capital Valuation Relative
28. [BrightView Holdings, Inc.](https://www.sectoralpha.in/us/stocks/bv) BV · turning · Most evidence points down · 71% evidence 30.4 out of 100 Growth Capital Valuation Relative
29. [Spire Global, Inc.](https://www.sectoralpha.in/us/stocks/spir) SPIR · quiet · Most evidence points down · 71% evidence 23.5 out of 100 Growth Capital Valuation Relative
30. [BUUU Group Limited](https://www.sectoralpha.in/us/stocks/buuu) BUUU · leader · Too little evidence to rank firmly · 42% evidence 49.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Business Services](https://www.sectoralpha.in/us/sectors/specialty-business-services), all 30 compared on one page. ## Which companies are close to Maximus in size? Maximus is the 15th largest of 31 Specialty Business Services companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: UniFirst Corporation, AZZ Inc. and First Advantage Corporation. Just below it: ABM Industries Incorporated, CBIZ, Inc. and TIC Solutions, Inc. ### Specialty Business Services companies close in size

1. [UniFirst Corporation](https://www.sectoralpha.in/us/stocks/unf) $4.6 billion
2. [AZZ Inc.](https://www.sectoralpha.in/us/stocks/azz) $4.1 billion
3. [First Advantage Corporation](https://www.sectoralpha.in/us/stocks/fa) $3.7 billion
4. Maximus, Inc. $3.4 billion
5. [ABM Industries Incorporated](https://www.sectoralpha.in/us/stocks/abm) $3.1 billion
6. [CBIZ, Inc.](https://www.sectoralpha.in/us/stocks/cbz) $3 billion
7. [TIC Solutions, Inc.](https://www.sectoralpha.in/us/stocks/tic) $2.3 billion

[All 31 Specialty Business Services companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-business-services#all-companies)

### Companies close in size in other industries

1. [WillScot Holdings Corporation](https://www.sectoralpha.in/us/stocks/wsc) $3.5 billion · Rental & Leasing Services
2. [Crane NXT, Co.](https://www.sectoralpha.in/us/stocks/cxt) $3.5 billion · Specialty Industrial Machinery
3. Maximus, Inc. $3.5 billion
4. [Mechanics Bancorp](https://www.sectoralpha.in/us/stocks/mchb) $3.5 billion · Banks - Regional
5. [First Financial Bancorp.](https://www.sectoralpha.in/us/stocks/ffbc) $3.5 billion · Banks - Regional

## What else do people ask about Maximus? ### What were Maximus's latest quarterly results? Maximus, Inc. reported revenue of $1.3 B and net profit of $104 M for the Jun 2026 quarter. Revenue fell 5.1% and profit fell 2.3% compared with a year earlier. Earnings per share were $1.95. The operating margin was 12.6%, 0.3 percentage points higher than a year earlier (as of 3 November 2026). ### What is Maximus's market cap? Maximus, Inc.'s market capitalisation is $3.4 B at a stock price of $65.46. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Maximus performing? Maximus, Inc.'s share price has been stalling near its high for 1 weeks. In its latest quarter, revenue fell 5.1% and profit fell 2.3% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 5 weeks running (as of 3 November 2026). ### Will Maximus's stock price go up? This page does not forecast Maximus, Inc.'s stock price. What it shows instead: the stock price is $65.46, and it has been stalling near its high for 1 weeks. Its P/E of 9.7× is higher than 12% of its own last 5 years (as of 3 November 2026). ### Where is Maximus in its business cycle? Maximus, Inc.'s FY25 operating margin was 9.7%, against a 5-year range of 6.0% to 9.8%: the middle of its own range, neither a peak nor a low. The latest quarter was 12.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Maximus story? The main question: yearly earnings per share moved +10.4% while the share price moved −21.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Maximus a stock worth studying right now? What the numbers show: Maximus, Inc.'s P/E is near the low end of its own history, higher than only 12% of past readings, and its quarterly results are still getting worse. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.